Kaposi's sarcoma is an important risk factor for survival in HIV-infected patients independent of CD4+ cell count [9]

AIDS

Volumn 13, Issue 3, 1999, Pages 432-433

  Husak, R ^a   Mansmann, U ^a   Wolfer, L U ^a   Geilen, C C ^a   Goerdt, S ^a   Orfanos, C E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; ZIDOVUDINE;

ADULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

ADULT; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; RISK FACTORS; SARCOMA, KAPOSI;

EID: 0032969858     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199902250-00024     Document Type: Letter

References (10)